Copyright
©2006 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. May 28, 2006; 12(20): 3237-3242
Published online May 28, 2006. doi: 10.3748/wjg.v12.i20.3237
Published online May 28, 2006. doi: 10.3748/wjg.v12.i20.3237
Updates on esophageal and gastric cancers
Amy Gallo, Resident, Department of Surgery, Yale University School of Medicine, 333 Cedar St., FMB 121, New Haven, CT 06520, United States
Charles Cha, Department of Surgery, Yale University of School of Medicine, 333 Cedar St., FMB 121, New Haven, CT 06520, United States
Author contributions: All authors contributed equally to the work.
Correspondence to: Charles Cha, MD, Assistant Professor, Department of Surgery, Yale University School of Medicine, 333 Cedar St., FMB 121, New Haven, CT 06520, United States. charles.cha@yale.edu
Telephone: +1-203-7852699 Fax: +1-203-7853346
Received: March 29, 2006
Revised: April 6, 2006
Accepted: April 16, 2006
Published online: May 28, 2006
Revised: April 6, 2006
Accepted: April 16, 2006
Published online: May 28, 2006
Abstract
Esophageal and gastric cancers are both common and deadly. Patients present most often after disease progression and survival is therefore poor. Due to demographic variability and recent changes in disease incidence, much emphasis has been placed on studying risk factors for both esophageal and gastric cancers. However, with increasing understanding of these diseases, low survival rates persist and continued intensive studies are necessary to optimize treatment plans. This review article discusses updates in the evolving epidemiology, clinical presentation, risk factors, and diagnostic and treatment modalities of esophageal and gastric cancers.
Keywords: Gastric cancer; Esophageal cancer; Surgery; Treatment